PROSTATE CANCER DIAGNOSIS IN 2019 - CHANGES IN EUROPEAN GUIDELINES AND IMPACT ON DAILY PRACTICE
- PMID: 34975191
- PMCID: PMC8693554
- DOI: 10.20471/acc.2019.58.s2.01
PROSTATE CANCER DIAGNOSIS IN 2019 - CHANGES IN EUROPEAN GUIDELINES AND IMPACT ON DAILY PRACTICE
Abstract
Changes in the diagnostic pathway for prostate cancer advised in the most recent Guidelines of the European Association of Urology bring many endeavors for everyday practice. Availability, costs and radiological expertise are still representing a challenge for the adoption of these guidelines in everyday clinical practice. In this article we discuss the current situation regarding these issues and future options.
Keywords: Guidelines; Multiparametric Magnetic Resonance; Prostate Cancer.
Figures
References
-
- Mottet N, van den Bergh RCN, Briers E, Cornford P, De Santis M, Fanti S, et al. EAU – ESTRO – ESUR – SIOG Guidelines on Prostate Cancer. https://uroweb.org/guideline/prostate-cancer. - PubMed
-
- Stabile A, Giganti F, Rosenkrantz AB, Taneja SS, Villeirs G, Gill IS, et al. Multiparametric MRI for prostate cancer diagnosis: current status and future directions. Nat Rev Urol. 2020. July 17 - PubMed
Publication types
LinkOut - more resources
Full Text Sources